Tolera Hires New CEO, Seeking Partner For Expansion
Tolera Therapeutics Inc., a pharma startup developing a novel T-cell targeted therapeutic platform, announced Tuesday that it has appointed Ashleigh Palmer as president, CEO and a member of its board.
